Astute Medical logo

Astute Medical

Enhancing rapid diagnosis and risk assessment in acute medical conditions through innovative protein biomarker identification and validation.

est. 2007

VS
SphingoTec logo

SphingoTec

Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time

30 employees · est. 2002 · Hennigsdorf, Germany

SphingoTec is the older company (2007 vs 2002).

Side-by-Side Comparison

Astute Medical SphingoTec
Founded
2007 2002 older
Headquarters
Not tracked yet Hennigsdorf, Germany
Employees
Not tracked yet 30
Industry
Biotechnology, Health Care Biotechnology
Funding Stage
Series Unknown Series B
Total Funding
$209.13M $1.50M
Funding Rounds
9 4
Services
Not tracked yet biomarker development, out-licensing of diagnostic solutions, critical care diagnostics, IVD assay provision
Target Customers
Not tracked yet research laboratories, pharmaceutical companies, critical care units, clinicians, transplant centers
Taxonomy
Biomarker Identification, Protein Biomarkers, Diagnostic Tests, Acute Medical Conditions, Rapid Diagnosis, Risk Assessment, Medical Diagnostics, Diagnostics Company, Medical Innovations, Abdominal Pain, Acute Coronary Syndromes, Cerebrovascular Injury, Kidney Injury, Sepsis Innovative Diagnostics, Acute Care, Biomarkers, Acute Heart Failure, Acute Kidney Injury, Circulatory Shock, Patient Management, Treatment Strategies, Health Risk Prediction, Obesity Biomarkers, Cardiovascular Disease Biomarkers, Breast Cancer Biomarkers, Sepsis Diagnostics, In Vitro Diagnostics, Blood-based Protein Biomarkers
Website
astutemedical.com sphingotec.com
Astute Medical logo

About Astute Medical

Astute Medical is a biotechnology startup that focuses on improving the diagnosis and risk assessment of critical medical conditions through the identification and validation of protein biomarkers for new diagnostic tests. Their primary focus is on acute conditions requiring quick diagnosis and risk...

SphingoTec logo

About SphingoTec

Founded in 2002, SphingoTec GmbH is a pioneering player in the Biotechnology sector, based in Germany. The company focuses on developing innovative biomarkers to diagnose, predict, and monitor acute medical conditions such as heart failure, kidney injury, and circulatory shock, with the aim of enhan...

We will tell you when either one moves

BounceWatch watches Astute Medical and SphingoTec for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Astute Medical and SphingoTec — by email.

Frequently Asked Questions

Astute Medical — Enhancing rapid diagnosis and risk assessment in acute medical conditions through innovative protein biomarker identification and validation.. SphingoTec — Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Astute Medical has raised $209.13M while SphingoTec has raised $1.50M.
Astute Medical and SphingoTec operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Astute Medical with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Astute Medical on 12 Sep 2024, and SphingoTec on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy